Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aromatic amino acids and modification of parkinsonism.

× No keyword cloud information.

229 in total

1. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

Authors: W Y Lee; J W Chang; N L Nemeth; U J Kang
Journal: J Neurosci Date: 1999-04-15 Impact factor: 6.167

2. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?

Authors: Curt R Freed
Journal: Proc Natl Acad Sci U S A Date: 2002-02-19 Impact factor: 11.205

3. Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.

Authors: A Barbeau
Journal: Can Med Assoc J Date: 1975-06-21 Impact factor: 8.262

Review 4. Parkinson's disease.

Authors: C D Marsden
Journal: Postgrad Med J Date: 1992-07 Impact factor: 2.401

5. Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.

Authors: J M Rabey; Y Vered; H Shabtai; E Graff; A D Korczyn
Journal: J Neurol Neurosurg Psychiatry Date: 1992-08 Impact factor: 10.154

6. The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.

Authors: S Consolo; H Ladinsky; S Bianchi; T Caraceni
Journal: Arch Psychiatr Nervenkr (1970) Date: 1977-05-16

7. Health-related quality of life as an outcome variable in Parkinson's disease.

Authors: Pablo Martinez-Martin; Mónica M Kurtis
Journal: Ther Adv Neurol Disord Date: 2012-03 Impact factor: 6.570

8. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Authors: Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Journal: Mov Disord Date: 2012-10-04 Impact factor: 10.338

9. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.

Authors: H L Klawans; W J Weiner
Journal: J Neurol Neurosurg Psychiatry Date: 1974-04 Impact factor: 10.154

10. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.

Authors: Gwenn S Smith; Kelly A Mills; Greg M Pontone; W Stanley Anderson; Kate M Perepezko; James Brasic; Yun Zhou; Jason Brandt; Christopher R Butson; Daniel P Holt; William B Mathews; Robert F Dannals; Dean F Wong; Zoltan Mari
Journal: Parkinsonism Relat Disord Date: 2019-04-16 Impact factor: 4.891